Dastila 50 mg Tablet
  1. Home
  2. Pharma Products
  3. Sun Pharmaceutical Industries Ltd
  4. Dastila 50 mg Tablet

Dastila 50 mg Tablet

Dastila 50 mg Tablet contains dasatinib 50 mg, a targeted anticancer medicine belonging to the tyrosine kinase inhibitor class. It is used to treat Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia. The tablet is taken orally according to the treatment plan prescribed by an oncologist.

BUY NOW

Category

Dasatinib works by inhibiting abnormal tyrosine kinase proteins, including BCR-ABL, that contribute to the growth of leukemia cells. Dastila 50 mg is used in specific treatment settings for Philadelphia chromosome-positive leukemia. It can be taken with or without food and should be swallowed whole with water. The product is marketed by Sun Pharmaceutical Industries Ltd, with a 12-tablet pack listed for this strength.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 50 mg
Dosage Form Tablet
Route of Administration Oral
Therapeutic Class Antineoplastic
Pack Size 12 tablets

Product Also Known As

Dastila 50 mg Tablet, Dastila 50mg Tablet, Dasatinib 50 mg Tablet, Dasatinib 50mg Tablet, Dasatinib Anticancer Tablet, Dasatinib Leukemia Tablet, BCR-ABL Inhibitor Tablet